CEO Q&A with Geremy Thomas at Sativa Investments PLC (NEX:SATI)

Sativa Investment PLC (NEX:SATI) Chief Executive Officer Geremy Thomas caught up with DirectorsTalk for an exclusive interview to discuss PhytoVista completing its 1000th cannabinoid and terpenes test.

 

Q1: Geremy, can you tell us about the types of cannabinoid and terpenes tests PhytoVista has completed so far?

A1: We’ve invested over £500,000 worth of test equipment to give us the ability to test samples that included cannabinoids and we are able to test for 14 different cannabinoids as well as testing for terpenes.

 

Q2: How is the 1000 tests significant for Sativa Investments?

A2: Well, it’s a good milestone for us, it demonstrates that the industry in the UK is receptive to the services we’re offering. It’s also a useful gage of the commercial development of the business, revenues are increasing month on month, and we see this as an integral part of the industry as the market develops.

 

Q3: Now, I understand that PhytoVista is working towards its ISO accreditation, what’s the current testing process?

A3: I think with any laboratory business relies on external accreditation to give credibility and the ISO 17000 that we’re going for is the first of those targets we have internally.

We are expanding our capabilities within the lab itself, we’re taking on more people, we’re buying more equipment and we’re extending the range of tests we can offer. We’re adding, very shortly, tests for heavy metals, mycotoxins and we will be targeting pesticide testing as well later in this year.

 

Q4: How is PhytoVista planning to expand for a larger market share?

A4: Currently, we are unique in as far as we are the only UK specialist that has this level of capability. There are competitors to the lab in Eastern Europe and Spain but it’s all about capability and turnaround ties and we aim to be at the forefront and continue to be market-leading against those measures.

 

PhytoVista Laboratories are Sativa Investments’ on-site testing facility. The increased growth of the CBD industry in the UK has led to a rise in the demand for high-quality testing and batch certification, with PhytoVista being a leading service provider.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Investments plc

    More articles like this

    DirectorsTalk

    CBD as a novel food: the UK’s stance post-Brexit

    The UK FSA’s announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the European Commission during the summer of 2020, who have currently ‘paused’ novel food

    DirectorsTalk

    What cannabinoids are found in CBD oils?

    CBD oils can be purely made from seeds or they can be a combination of cannabinoids, flavonoids, and terpenes. Every CBD oil is a little bit different, and you will want to make sure you read

    DirectorsTalk

    How the UK CBD industry is thriving in uncertain times

    This year covid-19 has hit hard with far-reaching economic implications for countries around the world. The United Kingdom is no exception as the economy has taken the brunt of the pandemic’s negative effects. However certain markets

    DirectorsTalk

    UK CBD market on a high

    Just when you thought the ‘hype’ around CBD adoption was a passing fad, UK’s nascent CBD market happens to be among the few industries maintaining an upward growth amidst the recent COVID-19 pandemic devastation in the

    DirectorsTalk

    How to integrate CBD oil into your diet

    The internet is awash with information and testimonies on the benefits of CBD oil and the potential that it has in alleviating a number of ailments. Whether or not some of these claims are true is

    DirectorsTalk

    Why should you choose CBD oil?

    Cannabidiol (CBD) is a non-psychoactive yet active chemical component among cannabinoids, a group of compounds found in marijuana plants otherwise known as Cannabis sativa. Conversely, Tetrahydrocannabinol (THC) is the principal psychoactive component that causes an intoxicating

    DirectorsTalk

    A guide to CBD

    What is CBD? CBD – It’s a relatively new product, but how can it benefit you? Most people haven’t even heard of it and yet it’s starting to appear in conversations around sports, food and beauty

    Sativa Group

    Is CBD oil legal in the UK?

    The legal status of CBD in the UK is reflected in many countries worldwide, with the main difference being the levels of THC allowed in the finished product. CBD has seen such a rapid rise to

    Sativa Group

    Sativa Group joins the ACI toxicology study

    As part of the Sativa Group PLC (AQUIS:SATI) ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the

    Sativa Group

    A comprehensive guide to CBD in the UK

    CBD is being added to products across the retail spectrum from food to make-up. According to claims by the Centre for Medical Cannabis, six million people in the UK have tried CBD, and this year the

    Sativa Group

    A new cannabis wellness era: A history of CBD

    Cannabis Sativa L. has been utilised for a large variety of ailments, industrial applications, and ceremonial uses for millennia. Evidence gathered from significant ancient sites has revealed that the plant was important, and even sacred, in

    Sativa Group

    How CBD can help level up your workout

    With gyms closed and group classes relegated to the online world, at-home workouts are the new normal. Feeling a bit lackluster after months of squats in your living room? Want a new solution so you can

    Sativa Group

    What is CBD? How does it work?

    What is CBD? It’s in everything from beauty products to lattes, but those three letters are thrown around so much that you’d be forgiven for not knowing what CBD is, exactly. More importantly, you might be wondering, is CBD safe?

    Sativa Group

    Sativa Group CSE conditionally approves Sativa Wellness Group

    Sativa Group plc (AQUIS:SATI) has announced that the Canadian Securities Exchange conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously